320 SOQUEL WAY, SUNNYVALE, CA
Announces Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency
Reports First Quarter 2026 Business Highlights and Financial Results
FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During Cell Therapy Procedures
AND JAPAN PMDA ALIGN ON ACCEPTABILITY OF CARDIAMP CLINICAL DATA TO SUPPORT REGULATORY APPROVAL IN ISCHEMIC HEART FAILURE
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Files Request for Meeting with FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
Reports 2025 Business Highlights and Financial Results
Q1
FY 2025
Q3
Amended Quarterly Report
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload